Font Size: a A A
Keyword [Olaparib]
Result: 1 - 20 | Page: 1 of 2
1. Synergistic Antitumor Interactions Between Obatoclax And Olaparib Or Chloroquine In Pancreatic Cancer Cells
2. Targeting DNA Repair Pathway In The Treatment Of Breast Cancer:Preclinical And Clinical Study
3. RAD51C Gene And Drug Sensitivity Of Eμ-Myc P19Arf-/- Cells And Its Expression In Breast Cancer Clinical Significance
4. The Expression Of APE1and The Relevance To Drug Susceptibility Of Olaparib In Triple-negative Breast Cancers
5. PARP Inhibitor Increases Chemosensitivity By Upregulating MiR-664b-5p In BRCA1-mutated Triple-negative Breast Cancer
6. The Expression Of APE1 In Breast Cancer And Its Effect On Drug Sensitivity Of Olaparib
7. Poly (ADP-ribose) Polymerase (PARP) Inhibitors For The Treatment Of Recurrent Epithelial Ovarian Cancer:a Meta-analysis
8. Effect Of Olaparib On The Colon Cancer Cell Lines With Low Expression Of ATM Gene
9. Synthetic Lethality Effects Of Ikk? Inhibition And Base Excision Repair Blockage On AML Cells
10. Studies On Synthesis And Bioactivities Of Olaparib Analogs And In Silico Screening For PARP-1 & AChE Dual-targeted Inhibitors
11. Effects Of Olaparib On The Atherosclerosis Process Of THP-1 Cells And Its Relationship With NLRP3 Inflammasome Activation
12. Antitumor Effects And Mechanisms Of Olaparib Combination With Carboplatin And BKM120 On Human Triple Negative Breast Cancer Cells
13. Mitogen-Activated Protein Kinase Inhibitors Increase Sensitivity Of Olaparib-Resistant Ovarian Cancer
14. The Sensitizing Effect Of Mir-509-3 On PARP Inhibitors In High-grade Serous Ovarian Cancer Based On PDX Models
15. Synthetic Lethal Interactions Between PARP Inhibition And Alantolactone-induced Oxidative DNA Damage In Cancer Cells
16. Investigating The Therapeutic Effect Of Olaparib And Palbociclib In Ovarian Cancer And Its Underlying Mechanism
17. The Study On The Biological Function And Related Mechanism Of RECQL4 In Serous Ovarian Cancer
18. A Meta-analysis Of The Clinical Efficacy And Safety Of Olaparib Maintenance Therapy In Patients With Recurrent Epithelial Ovarian Cancer
19. The Study On The Synergistic Anti-cancer Effects Of ROS Elevating Drugs And PARP Inhibitors
20. Olaparib Nanoparticles Potentiated Radio-sensitization Effects On Lung Cancer
  <<First  <Prev  Next>  Last>>  Jump to